SCHEMBL22728368

SCHEMBL22728368

C=C(c1cccnc1-c1ccncc1)N1CCC(C#N)(Cc2cccc(C(F)(F)F)c2F)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ P2RX7 Q99572 5/20 0.32
▸ KCNH2 Q12809 3/20 0.31
▸ PKLR P30613 1/20 0.31
▸ TRPV1 Q8NER1 1/20 0.31
▸ RBP4 P02753 1/20 0.31
▸ JAK2 O60674 1/20 0.30
▸ JAK1 P23458 1/20 0.30
▸ KCNA5 P22460 1/20 0.30
▸ SCN5A Q14524 1/20 0.30
▸ SCN9A Q15858 1/20 0.30
▸ TEC P42680 1/20 0.30
▸ TXK P42681 1/20 0.30
▸ BMX P51813 1/20 0.30
▸ BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22728298 0.92 CYP46A1 (0.43) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL24709774 0.90 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453793 0.90 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728495 0.84 CYP46A1 (0.39) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728370 0.82 CYP46A1 (0.44) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453797 0.82 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719295 0.82 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728374 0.81 CYP46A1 (0.43) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719376 0.80 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453735 0.80 CYP46A1 (0.53) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback